Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 1

The relation of CRP and homocysteine levels and multivessel disease in acute coronary syndrome

Akut koroner sendromlu bireylerde C-reaktif protein (CRP) ve homosistein düzeylerinin çok damar hastalığı ile ilişkisi

Pages
4–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Finally, using the scoring system in diabetic or nondiabetic patients, the relationship between the severity of multivessel coronary disease and homocysteine and/or CRP levels were statistically insignificant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: High homocysteine level and/or C-Reactive Protein (CRP) levels are not only related to atherosclerosis but al­so to the severity of coronary artery disease.
📊
Key Findings & Data:Material and Method: We studied 83 patients who were referred for coronary angiography with acute coronary syn­dro­me.
💡
Conclusion & Impact:Conclusion: Finally, using the scoring system in diabetic or nondiabetic patients, the relationship between the severity of multivessel coronary disease and homocysteine and/or CRP levels were statistically insignificant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:C-reaktif protein · Koroner hastalık · Homosistein

Abstract

Aim: High homocysteine level and/or C-Reactive Protein (CRP) levels are not only related to atherosclerosis but al­so to the severity of coronary artery disease. In this study we aimed to determine the relation of multivessel co­ro­nary disease and homocysteine and CRP levels in acute coronary syndrome. Material and Method: We studied 83 patients who were referred for coronary angiography with acute coronary syn­dro­me. The relation between serum homocysteine and CRP levels and the severity and extension of coronary le­sions was studied. The coronary angiograms were evaluated according to three scores. Vessel score (0-3 points for 0-3 vessels with coronary artery disease), stenosis score (0-3 points; number and severity of coronary stenoses or lesions; 0 for no, 1 for coronary lesion with diameter stenosis less than %50, 2 for %50-%75 and 3 for more than %75 diameter stenosis), and extension score (0-3 points; segment-extension of all coronary lesions within the total co­ronary vessel length). Finally the total score values obtained from the vessel score, stenosis score, and extent sco­re. From the 83 patients, 11 were found to have no or minimal coronary artery disease (group A; score 0-3), 45 had moderate (group B; score 4-6) and 27 had severe (group C; score 7-9) coronary artery disease assessed by co­ronary angiography. For the statistical analysis Kruskal-Wallis test had been used. Results: In moderate(Group B) and severe groups of coronary artery disease, CRP levels were found higher than mild group but the difference was found to be insignificant with Kruskal-Wallis method (table 1) (Group A: 5.33±3.71 mg/L, Group B: 8.41±11.40 mg/L, Group C: 6.76±10.80 mg/L, p>0.05). In moderate(Group B) group of co­ronary artery disease, homocysteine levels were found higher than mild group but there was no statistically sig­ni­fi­cant differences with Kruskal-Wallis method. (Group A: 14.89±4.12 mikromol/L, Group B: 16.97±6.21 mikromol/L, Gro­up C: 14.82±4.16 mikromol/L, p>0.05). On the other hand, in nondiabetic patients (table 2); In moderate(Group B) and severe groups of coronary artery disease, CRP levels were found more than mild group but there was no sta­tistically significant differences with Kruskal-Wallis method. (Group A: 5.61±3.95 mg/L, Group B: 7.05±8.45 mg/L, Group C: 6.72±8.72 mg/L, p>0.05). In moderate(Group B) group of coronary artery disease, homocysteine le­vels were found higher than mild group but there was no statistically significant differences with Kruskal-Wallis met­hod. (Group A: 17.38±4.99 mikromol /L, Group B: 18.40±6.95 mikromol/L, Group C: 15.32±4.77 mikromol/L, p>0.05). In addition to these findings, there was no statistically significant relationship between severe CAD and ho­mocysteine and/or CRP levels in diabetic patients. Conclusion: Finally, using the scoring system in diabetic or nondiabetic patients, the relationship between the severity of multivessel coronary disease and homocysteine and/or CRP levels were statistically insignificant.

Özet

Amaç: Artmış homosistein ve CRP düzeyinin koroner ateroskleroz için sadece bağımsız bir risk faktörü olmadığı, ay­nı zamanda koroner ateroskleroz miktarı ve yaygınlığı ile de ilşkisinin olduğunu destekleyen veriler mevcuttur. Bu ça­lışmanın amacı akut koroner sendromlu hastalarda CRP ve homosisteinin, çok damar hastalığı ile ilişkisi olup ol­ma­dığının saptanmasıdır. Gereç ve Yöntem: Çalışmaya akut koroner sendromlu 83 hasta alınmıştır. Hasta grubunda anjiografik olarak tespit e­dilen damar tutulum sayısı, yaygınlığı, stenoz şiddeti ve damar skoru ile homosistein ve CRP düzeyleri kar­şı­laş­tı­rıl­mış­tır.Damar skoru; (0-3 puan; damar tutulum sayısına göre), stenoz skoru; (0-3 puan: 0 puan: darlık yok, 1; %50’nin altında darlık, 2; %50-%75 arasında lezyon, 3; %75’ten fazla darlık), yayılım skoru; (0-3 puan: toplam lez­yon uzunluğunun segment tutulumuna göre yayılım). Bu 3 skorun toplamından, toplam skor bulunmuştur. 83 has­ta­nın 11’inde normal ya da minimal koroner arter hastalığı (Grup A: skor 0-3), 45’inde orta şiddette koroner arter has­ta­lığı (Grup B: skor 4-6), 27’sinde ciddi koroner arter hastalığı ( Grup C: skor 7-9) saptandı. İstatistiksel analiz için Krus­kal-Wallis yöntemi kullanıldı. Bulgular: Orta şiddette (Grup B) ve ağır şiddette (Grup C) koroner arter hastalığı olan bireylerde CRP seviyesi ha­fif şiddettekilere (Grup A) göre daha fazla bulunmuştur, ancak bu fark istatistiksel olarak anlamlı bulunmamıştır (Grup A: 5.33±3.71 mg/L, grup B: 8.41±11.40 mg/L, Grup C: 6.76±10.80 mg/L p>0.05). Orta şiddette (Grup B) ko­ro­ner arter hastalığı olan bireylerde homosistein seviyeleri hafif şiddette koroner arter hastalığı olanlara göre daha faz­la bulunmuştur (Group A: 14.89±4.12 mikromol /L, Group B: 16.97±6.21 mikromol/L, Group C: 14.82±4.16 mik­romol/L, p>0.05). Diğer taraftan, diabetik olmayan hastalarda orta şiddette (Grup B) ve ağır şiddette (Grup C) ko­roner arter hastalığı olanlarda CRP seviyesi koroner arter hastalığı hafif olan bireylere göre daha yüksek bulundu an­cak bu fark istatistiksel olarak anlamlı bulunmadı (Group A: 5.61±3.95 mg/L, Group B: 7.05±8.45 mg/L, Group C: 6.72±8.72 mg/L, p>0.05). Orta şiddette (Grup B) koroner arter hastalığı olan hastalarda homosistein seviyesi mi­ni­mal şiddetteki koroner arter hastalarına göre daha yüksek bulundu ancak Kruskal-Wallis yöntemiyle istatistiksel fark­lılık saptanmadı. (Group A: 17.38±4.99 mikromol /L, Group B: 18.40±6.95 mikromol/L, Group C: 15.32±4.77 mik­romol/L, p>0.05). Tüm bunlara ek olarak diabetik hastalarda ciddi koroner arter hastalığı ile homosistein ve/veya CRP seviyeleri arasında anlamlı bir ilişki saptanmadı. Sonuç: Sonuçta yapmış olduğumuz çalışmada, akut koroner sendromlu bireylerde diabetik olsun veya olmasın, CRP ve homosistein seviyesi ile çok damar hastalığı arasında istatistiksel olarak anlamlı bir ilişki saptanmamıştır.

🔖

Cite This Article

CONKBAYIR, C., ONGUN, A., BETON, O., KUMBASAR, D., TUTAR, E., ATMACA, Y., ORAL, D., EROL, Ç. (2006). The relation of CRP and homocysteine levels and multivessel disease in acute coronary syndrome. MN Kardiyoloji, Cilt: 13 - Sayı: 1, 4–14. https://ajindex.com/articles/299112

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Levy D, Wilson PW. Atherosclerotic cardiovascular disease: An epidemiologic perspective. In Topol EJ ed. Textbook of cardiovascular Medicine, Philedelphia, Lipincott-Raven Publishers 1997:14. 2.Goncalves LM. Angiogenic growth factors: Potential new treatment for acute myocardial infarction. Cardiovasc Res. 2000
  2. Stampfer MJ, Mainow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992
  3. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ische-mic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998
  4. Arnesen E, Refsum H, Bonaa KH, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995
  5. Haverkate F, Thompson SG, Pyke SDM, et al. for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997
  6. Pietila KO, Harmoinen AP, Jokinitty J, et al. Serum C-reactive protein concentration an acute myocardial infarction and its relation to mortality during 4 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996
  7. Robinson K, Loscalzo J. Other risk factors for coronary artery disease: Homocysteine, Lipoprotein (a), Fibrinogen and Plasmi-nogen Activator Inhibitor. In Topol EJ. Ed. Textbook of Cardiovascular Medicine, Philedelphia, Lipincott-Raven Publishers 1997:232-6. 9.Torzewski M, Rist C, Mortensen RF, et al.: C-reactive protein in the arterial intima: role of C-reactive protein receptor -dependent monocyte recruitment in atherogenesis. Arterioscler Th-romb Vase Biol 2000
  8. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tisuue factor. Blood 1993
  9. Montalescent G, Ankri A, Chadefaux- Vekemans B, et al. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol 1997
  10. Schnyder G, Pin R, Roffi M, et al. Association of plasma homocysteine with the number of major coronary arteries severely narrowed. Am J Cardiol 2001
  11. Chao CL, Tsai HH, Lee CM, et al. The graded effect of hyp-erhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis. 1999
  12. Verhoef P, Kok FJ, Kruyssen DACM, et al.